One Month of Wegovy Weight Loss: What the First Four Weeks Actually Look Like

The biggest myth: a slow first month means Wegovy isn't working

Here it is, stated plainly, so we can put it to rest: a modest or even flat first month on Wegovy is not a sign of failure. It is almost always a sign that you are at the starting dose.

Wegovy's titration schedule begins at 0.25mg weekly. That dose exists for one reason, to reduce nausea and other gastrointestinal side effects while your system adapts. It is not a therapeutic weight-loss dose. The NHS medicines page for semaglutide describes this stepped approach clearly: doses increase roughly every four weeks, moving through 0.5mg, 1.0mg and 1.7mg before reaching the 2.4mg maintenance level. Some people now titrate further to 7.2mg, following MHRA approval of that higher dose in early 2026. Most patients spend the entirety of month one at 0.25mg. A small reduction in appetite, perhaps some nausea, sometimes nothing noticeable at all, that is a completely ordinary first four weeks.

People who come to us having read about 15% weight loss in clinical trials sometimes worry that their month-one results suggest they are in the non-responder minority. Usually they are not, and if you want a detailed picture of what one month on Wegovy typically looks like in terms of weight loss, including what counts as a normal range at this early stage, we cover that in full. They are just at the beginning of a process that takes months, not weeks.

What the trial data actually shows for early weight loss on Wegovy

The STEP 1 trial, which underpins Wegovy's NICE approval, followed nearly 2,000 adults without diabetes over 68 weeks. Average weight loss at the 2.4mg maintenance dose reached approximately 15% of starting body weight by the end, a figure cited in NICE's technology appraisal TA875. That is the final destination, not the month-one snapshot.

Across the trial, meaningful weight loss built gradually. The steepest reductions tended to occur once participants were established on higher doses, typically from around week 12 onwards. Early weeks showed more modest changes. If you are looking at how Wegovy weight loss tracks month by month, the curve is not a straight line from week one, it accelerates as the dose increases.

For people asking about one month on Wegovy with no weight loss at all: this too sits within the normal range at the 0.25mg starting dose. Appetite suppression is mild at this level. Calorie intake may not shift much. Weight can even fluctuate slightly upward due to water retention or normal variation. That changes once titration progresses.

What actually drives results in the first month and beyond

A few things influence how much weight someone loses in their first month on Wegovy. Starting body weight matters: people with a higher BMI tend to lose more in absolute kilograms early on, though percentage loss often levels out over time. How well the GI side effects are tolerated matters too, if nausea reduces your appetite significantly at 0.25mg, you may see more early movement. Dietary habits during this period play a role; Wegovy works alongside a reduced-calorie diet and increased activity, not instead of them.

What does not reliably predict final results is the month-one number. There is no clinical threshold at four weeks that determines whether someone will respond well. If you are at six months on a maintenance dose and have lost less than 5% of your starting weight, that is the point at which your prescriber would review whether continuing makes sense, not at week four on the starter dose.

The cost of treatment over time is a reasonable question at this stage. You can find a clear breakdown of what private Wegovy treatment includes on our Wegovy price and cost page, including what a single transparent monthly price covers.

What to expect from months three and six, and when to speak to a prescriber

By month three, most people are at or approaching the 1.7mg or 2.4mg dose, and the difference in appetite suppression is usually noticeable. The three-month Wegovy weight loss picture tends to be more representative of how the medicine is working for you as an individual. By six months, the evidence base suggests substantial average losses, our six-month Wegovy results page covers this in detail, drawing directly from trial data.

Side effects are worth knowing about throughout. The most common ones (nausea, loose stools, reflux, reduced appetite, fatigue) are typically most pronounced after a dose increase and settle within a week or two for most people. The NHS recommends contacting a healthcare professional promptly if you experience severe, persistent abdominal pain that may spread to the back, which can occasionally signal a problem with the pancreas. You can report any suspected side effects through the MHRA's Yellow Card scheme.

If you have specific questions about your own titration, how to interpret your progress, or whether your starting dose is right for you, the right place to take those is a clinical consultation. Our prescribers review every patient individually, no automated decisions. If you want to understand more about semaglutide and how it works before starting, the semaglutide overview page covers the mechanism and evidence in full.

Ready to discuss where you are in your journey? Speak to our prescribers, the consultation is free and reviewed the same day.